Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting

Go back to Vaxart’s Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
(NASDAQ: VXRT) Delayed: 0.32 --0 (-0%)
Previous Close $0.32    52 Week High
Open $0.32    52 Week Low
Day High $0.32    P/E N/A 
Day Low $0.32    EPS
Volume 8,628